Navigation Links
HeartSine® Technologies Named One of the Most Innovative Businesses in the United Kingdom
Date:9/6/2011

NEWTOWN, Pa., Sept. 6, 2011 /PRNewswire/ -- HeartSine® Technologies, Inc., a world leader in personal and public access defibrillators, announced that it is a finalist to receive the coveted Orange Innovation Award in the 10th annual UK National Business Awards. HeartSine was selected because of its innovative approach to the design, development and manufacture of Automated External Defibrillators (AED) for the treatment of Sudden Cardiac Arrest.

The Orange Innovation Award recognizes businesses that have gone beyond the ordinary in their development and who have implemented cutting edge innovation in terms of products, services or company culture. The clinically advanced technology within HeartSine's leading edge cardiac defibrillation products enables the company to compete successfully in the global healthcare market.

HeartSine's Public Access Defibrillator (PAD) devices meet and exceed AED clinical efficacy standards. This innovation enables HeartSine to provide its global customers with exceptional product reliability, the lowest cost of ownership and superior technology that helps save lives.

"Our long history of invention and innovation in the AED industry continues today in our ongoing commitment to developing and providing the highest level of clinically advanced, lifesaving technology to customers around the globe," said Marc Lawrence, senior vice president, HeartSine. "We are honored to have been selected as a finalist for this prestigious award."

HeartSine will prepare a presentation in person before an independent panel of experts in October. Winners will be announced in November at an awards ceremony in London.  

About HeartSine Technologies

A world leader in personal and public access defibrillators, HeartSine's mission is to advance the deployment of lifesaving defibrillation therapy in non-traditional areas of care. HeartSine® samaritan® PAD (Public Access Defibrillator) is the only medical device specifically designed for public access use to administer lifesaving treatment for Sudden Cardiac Arrest. It's lifesaving, pure and simple.

For more information, please contact info@heartsine.com, call (866) 478-7463, ext. 112, or visit www.heartsine.com.

Download a high-res photo of the samaritan® PAD 300P: http://www.ggcomm.com/HeartSine/PAD300P.jpg

121 Friends Lane
Suite 400
Newtown, PA 18940
Phone: 215.860.8100 ext. 112
Contact: Stacey Lock
stacey.lock@heartsine.com


'/>"/>
SOURCE HeartSine Technologies, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Shock for Life and HeartSine® Technologies Now Exclusive Providers of Lifesaving AED Solution to Wegmans Food Markets
2. HeartSine® Technologies Donates Lifesaving AED to Camphill Special School
3. HeartSine® Increases AED System Warranty to Longest in the Industry
4. Auxilium Pharmaceuticals, Inc. and BioSpecifics Technologies Corp. Announce Plans to Develop Additional Indications using XIAFLEX®
5. ChemOutsourcing Announces the 62 Exhibitors to Present API & New Chemical Technologies at September 12-15, 2011 Show in NJ
6. VacChina 2011 - Bridging the China Vaccine Industry with the World Class Biotechnologies
7. China Medical Technologies Reports First Fiscal Quarter Financial Results
8. Patient Safety Technologies Reports Second Quarter 2011 Results
9. Deloitte Stakes Claim in Drug Safety & Regulatory Consulting Market With Acquisition of Intrasphere Technologies, Inc. Assets
10. Althea Technologies Hosts Health and Wellness Week
11. China Medical Technologies Announces SFDA Approvals for its Prostate Cancer FISH Detection Kit and TOP2A FISH Detection Kit
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... , June 26, 2016 ... value-based care operating models within the health care industry ... greater financial efficiency , Deloitte offers a suite ... key business issues impacting efficient cost optimization: labor resource ... , These services facilitate better outcomes and better economics ...
(Date:6/24/2016)... 24, 2016  Global Blood Therapeutics, Inc. (GBT) (NASDAQ: ... novel therapeutics for the treatment of grievous blood-based ... closing of its previously announced underwritten public offering ... public offering price of $18.75 per share. All ... by GBT. GBT estimates net proceeds from the ...
(Date:6/24/2016)... Research and Markets has ... 2015-2025: Applications, Technologies, Forecasts" report to their ... Electronics, Smart Skin, Structural Health Monitoring, Composite Smart ... electronics involves electronic and/or electrical components and circuits ... structures such as vehicle bodies or conformally placed ...
Breaking Medicine Technology:
(Date:6/26/2016)... ... June 26, 2016 , ... ... have been diagnosed with endometriosis. These women need a treatment plan to not ... comprehensive approach that can help for preservation of fertility and ultimately achieving a ...
(Date:6/25/2016)... TX (PRWEB) , ... June 25, 2016 , ... ... the United States, named Dr. Sesan Ogunleye, as the Medical Director of its new ... the facility Medical Director of our new Mesquite location,” said Dr. James M. Muzzarelli, ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article published June 14 ... The article goes on to state that individuals are now more comfortable seeking to ... operations such as calf and cheek reduction. The Los Angeles area medical group, Beverly ...
(Date:6/24/2016)... ... , ... Global law firm Greenberg Traurig, P.A. announced that 20 Florida attorneys ... peers for this recognition are considered among the top 2 percent of lawyers practicing ... members of this year’s Legal Elite Hall of Fame: Miami Shareholders Mark D. ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... ... today at the Clinical Decision Making in Emergency Medicine conference in Ponte Vedra ... authored journal articles published in Emergency Medicine Practice and Pediatric Emergency ...
Breaking Medicine News(10 mins):